Clinical Trial

Trial to Improve Fertilization Rate and Embryo Development in Intracytoplasmic Sperm Injection (ICSI) Cycles

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The Aim of the trial: Assess if a consecutive second ejaculate contains an equal, or even higher number of motile sperm and produces high-quality sperm for intracytoplasmic sperm injection (ICSI) in male factor patients and if it will improve clinical outcomes, such as fertilization rate, embryo quality, number of blastocysts retrieved per cycle, implantation, and hopefully pregnancy rates.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-29; most recent amendment 2026-01-01.
Status change: Recruiting → Active, Not Recruiting 2026-01-01
Trial Details
NCT Number NCT07056400
Lead Sponsor Ain Shams University
Conditions Male Infertility
Enrollment 108 participants
Start Date 2024-04-03
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-05